- Home
- / Creo Medical
Creo Medical
Stock Price
£0.2
2024-10-29
Market Capitalization
£81.4 M
2024-10-29
Revenue
£8.8 M
FY, 2025
Creo Medical Summary
Company Summary
- Overview
- Creo Medical Group (formerly known as MicroOncology) is a company that specializes in the development and commercialization of minimally invasive electrosurgical devices. It offers resection, diagnosis, therapeutics, and hygiene products for urology, gastroenterology, pulmonology, and advanced energy sectors.
- Type
- Public
- Status
- Active
- Founded
- 2003
- HQ
- Chepstow, GB | view all locations
- Cybersecurity rating
Table of Contents
Key People
Craig Gulliford, Chief Executive Officer and Founding Angel Investor, Director
Richard Rees, Chief Finance Officer and Director
Chris Hancock, Founder & Chief Technology Officer and Director
LocationsView all
8 locations detected
Chepstow, Wales HQ
United Kingdom
Creo House, Unit 2 Beaufort Park, Beaufort Park Way
Danbury, CT
United States
100 Reserve Rd b400
Anderlecht, Bruxelles
Belgium
Rue des Vétérinaires 42
Saint-Dié-des-Vosges, Grand Est
France
9 Av. Jean Prouvé
Langenfeld (Rheinland), NRW
Germany
Hans-Böckler-Straße 29
Singapore
Singapore
8 Commonwealth Ln, #04 03c
Creo Medical Financials
Summary Financials
- Revenue (FY, 2025)
- £8.8M
- Gross profit (FY, 2025)
- £5.8M
- Net income (FY, 2025)
- £5.3M
- Cash (FY, 2025)
- £12.4M
- EBIT (FY, 2025)
- £5.3M
- Enterprise value
- $73.1M